Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc.（RYTM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
rytm · 股价预测 · 20 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 20 位华尔街分析师
Buy
20 位分析师
共识
评级分布
12 个月目标价
High
$157
Consensus
$140
+63.2% upside
Low
$125
Median: $143 · Last Close: $85.93
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$140.20
63.2% upside
High Target
$157
82.7%
Low Target
$125
45.5%
Current Price
$85.93
as of today
Based on analyst price targets, the RYTM stock price prediction for the next 12 months ranges from $125 to $157. The consensus RYTM price forecast of $140.20 implies 63.2% upside from the current price of $85.93.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $83.83 | ↓ 2.45% |
1-day model range: $83.32–$84.33. Peak: $84.33 (-2.45%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $131 | +52.7% |
| 2028 | $173 | +101.1% |
| 2029 | $206 | +139.2% |
| 2030 | $229 | +166.5% |
| 2031 | — | +184.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RYTM · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-06 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-20 | B of A Securities | Maintains | Buy→Buy |
| 2026-03-20 | Citigroup | Maintains | Buy→Buy |
| 2026-03-20 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-17 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-17 | Morgan Stanley | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Rhythm Pharmaceuticals, Inc. (RYTM) stock. Of the recent 146 rating actions, 7 were upgrades and 5 were downgrades. 20 analysts currently cover RYTM.
分析师推荐趋势
RYTM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$298M
↓ 65.9% YoY
Revenue Next Year
$541M
↑ 81.5% YoY
EPS This Year
$-3.15
EPS Next Year
$-0.74
↓ 76.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast RYTM EPS of $-3.15 for the current fiscal year, based on estimates from 9 analysts. The RYTM revenue forecast is $298M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
RYTM 股价预测由两类独立数据源支撑：来自 20 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RYTM 的共识目标价为 $140.20（+63.2% 上行空间），分析师共识为 Buy。
RYTM 的短期预测（明日）为 $83.83（-2.45%）。 RYTM 对 2027 年的股价预测均值为 $131。 RYTM 对 2030 年的预测区间为 $214–$244。
Rhythm Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 RYTM。RYTM 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
RYTM 预测 · 8 个问题根据 20 位华尔街分析师，RYTM 的 12 个月平均目标价为 $140.20，最高 $157.00、最低 $125.00。若有图表，中位目标价可在上方查看。相对当前价 $85.93，隐含约 +63.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.